THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS

Pierre Ambroise-Thomas
  • Pierre Ambroise-Thomas
    Société de pathologie exotique, 20, rue Ernest-Renan, F-75015, Paris, France. socpatex@pasteur.fr, Italy | socpatex@pasteur.fr

Abstract

Counterfeit antimalarials (mainly artemisinin derivatives) is a crucial health problem in developing countries, particularly in Africa. The illegal production, sale and distribution of fake drugs is a huge market evaluated to several billion of dollars and represents more than 50% of the pharmaceutical market in several African countries. Fake drugs have led to a very great number of deaths from untreated malaria or fatality provoked by toxic ingredients. These fake medicines increase the risk of artemisinin resistance developed by the use of sub therapeutic dosages of antimalarials. Tackling this criminal traffic is the objective of an international  programme created by WHO  and involves the international police and custom organizations like INTERPOL. Several very important and encouraging results have been obtained, but the problem will be completely solved if genuine antimalarials, free-of-charge, are handed-over to populations in sub Sahara African countries.

 

 

Keywords

Malaria, Antmalaric Drugs , Fake drugs

Full Text:

PDF
HTML
Submitted: 2014-06-13 09:28:25
Published: 2012-05-04 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
837

Views:
PDF
295
HTML
1073

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185